Immumem Therapeutics
Immumem Therapeutics develops induced pluripotent stem cell-derived cell therapy platforms for biotech research.
Pre Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredNov 10, 2024 (2 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Pre Seed | undisclosed | — | — |
Timeline
- Website created
Founders and team
- S(Shubhranshu (Shubh) Gupta CEO/Chief Scientific Officer (CSO), President & Foundersource: immumemtx.com
Companies like Immumem Therapeutics
SSyntax$14.4M · Jun 2026BBioCardia$4.4M · Jun 2026
SStemSight$2.3M Seed · Feb 2025RRejuvStemSeed · Sep 2026
CCellogen Therapeutics$2.08M Seed · May 2026
RResolution TherapeuticsSeries B+ · Oct 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/immumem-therapeutics (get a free API key).